Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.
Conditions
- Systemic Lupus Erythematosus
Interventions
- OTHER: None (Observational study)
Sponsor
AstraZeneca
Collaborators